FMED
Fidelity Disruptive Medicine ETF
Set alert
32.41 USD -0.87 -2.61%
32.11 Day range 33.20
23.55 52-week range 33.45
- YTD
- +19.82%
- 1 year
- +23.42%
- Open
- 33.18
- Prev close
- 33.28
- Mkt cap
- 76.48M
- Vol
- 7.64K
- Avg vol
- 8.19K
- EPS
- 0.705577
- P/E
- 45.94
- Div yield
- 0.00%
More statistics
- Low
- 32.11
- High
- 33.20
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 25.84
- 200-d avg
- 25.06
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 39.60
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 25.84
- 200-day average
- 25.06
About Fidelity Disruptive Medicine ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.
News
- Fidelity Investments® Announces Liquidation of Five Exchange-Traded Funds
- Innovative ETF Strategies That Are Paying Off This Summer
- Disruptive Healthcare Stocks ETF FMED Hits Milestone in June
- 2 ETFs That Capitalize on the “Silver Tsunami”
- AI Opens The Door to This Active Healthcare ETF
- Investing in the Future of Healthcare
- Exploring Key Tailwinds for Fidelity's Disruptive ETFs
- First Look At FMED: Poor Performance Merits A Strong Sell Rating
- Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
- As Biotech Outlook Grows Healthier, Look to Disruptive ETF FMED
Your note
Sign in to keep a note on FMED — it syncs with the Stock Master app.